Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess

• Main Authors: Mingming Li (Author), Ruxu You (Author), Yuyong Su (Author), Hongbo Zhou (Author), Shiwei Gong (Author)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Introduction: Tumor necrosis factor (TNF) inhibitors (adalimumab, infliximab, etanercept, golimumab, and certolizumab pegol) have revolutionized the treatment of severe immune-mediated inflammatory diseases, including rheumatoid arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondy...